Literature DB >> 17462948

Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP.

Lars Lüthje1, Dirk Vollmann, Till Drescher, Peter Schott, Dieter Zenker, Gerd Hasenfuss, Christina Unterberg.   

Abstract

BACKGROUND: An alert algorithm, based on intrathoracic impedance monitoring, has been incorporated into a cardiac resynchronisation device (CRT) to detect pulmonary fluid accumulation, and to audibly alert patients to decompensating chronic heart failure (CHF). AIMS: To evaluate this algorithm, alert events were correlated with changes in NT-proBNP concentration and CHF status. METHODS AND
RESULTS: In a prospective observational study of 62 patients (89% male, aged 67+/-1 year), NT-proBNP plasma concentrations, clinical CHF status, and device data were collected at enrolment, during regular follow-up and at device alerts. Over a mean follow-up of 27+/-2 weeks, pooled data indicated a weak, but significant inverse relationship between relative changes in intrathoracic impedance and NT-proBNP (r=-0.3; p<0.001). In 52 device alerts from 35 patients, NT-proBNP increased by 66+/-19% from 2039+/-331 pg/ml (p<0.001). The increase in NT-proBNP was higher in alerts with clinical signs of CHF deterioration (n=30, 89+/-25%; p<0.001) than in alert events without clinical signs (n=22, 25+/-15%; p=n.s.).
CONCLUSION: Intrathoracic impedance based alert events are associated with a significant increase in NT-proBNP concentration. These data indicate that intrathoracic impedance monitoring might facilitate the outpatient management of CHF patients with implanted CRT devices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462948     DOI: 10.1016/j.ejheart.2007.03.005

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  7 in total

1.  Intrathoracic impedance monitoring detecting pneumonia.

Authors:  Christine Barth; I Kindermann; F Mahfoud; A Buob; M Böhm
Journal:  Clin Res Cardiol       Date:  2010-02-18       Impact factor: 5.460

2.  Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.

Authors:  Michael R Zile; Vinod Sharma; James W Johnson; Eduardo N Warman; Catalin F Baicu; Tom D Bennett
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

3.  Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization.

Authors:  Giovanni B Perego; Maurizio Landolina; Giuseppe Vergara; Maurizio Lunati; Gabriele Zanotto; Alessia Pappone; Gabriele Lonardi; Giancarlo Speca; Saverio Iacopino; Annamaria Varbaro; Shantanu Sarkar; Doug A Hettrick; Alessandra Denaro
Journal:  J Interv Card Electrophysiol       Date:  2008-09-23       Impact factor: 1.900

Review 4.  Leveraging cardiac resynchronization therapy devices to monitor patients with heart failure.

Authors:  Jeffrey Wing-Hong Fung; Cheuk-Man Yu
Journal:  Curr Heart Fail Rep       Date:  2008-03

Review 5.  Measuring impedance in congestive heart failure: current options and clinical applications.

Authors:  W H Wilson Tang; Wilson Tong
Journal:  Am Heart J       Date:  2008-12-16       Impact factor: 4.749

6.  Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk.

Authors:  Wai Hong Wilson Tang; Eduardo N Warman; James W Johnson; Roy S Small; James Thomas Heywood
Journal:  Eur Heart J       Date:  2012-06-07       Impact factor: 29.983

7.  Natriuretic Peptide testing in primary care.

Authors:  Shafiq U Rehman; James L Januzzi
Journal:  Curr Cardiol Rev       Date:  2008-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.